JP2024525368A5 - - Google Patents

Info

Publication number
JP2024525368A5
JP2024525368A5 JP2023578050A JP2023578050A JP2024525368A5 JP 2024525368 A5 JP2024525368 A5 JP 2024525368A5 JP 2023578050 A JP2023578050 A JP 2023578050A JP 2023578050 A JP2023578050 A JP 2023578050A JP 2024525368 A5 JP2024525368 A5 JP 2024525368A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
disease
condition
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073385 external-priority patent/WO2023279105A1/en
Publication of JP2024525368A publication Critical patent/JP2024525368A/ja
Publication of JP2024525368A5 publication Critical patent/JP2024525368A5/ja
Pending legal-status Critical Current

Links

JP2023578050A 2021-07-01 2022-07-01 アゼチジニルピリミジンおよびその使用 Pending JP2024525368A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163217607P 2021-07-01 2021-07-01
US63/217,607 2021-07-01
PCT/US2022/073385 WO2023279105A1 (en) 2021-07-01 2022-07-01 Azetidinyl pyrimidines and uses thereof

Publications (2)

Publication Number Publication Date
JP2024525368A JP2024525368A (ja) 2024-07-12
JP2024525368A5 true JP2024525368A5 (cg-RX-API-DMAC7.html) 2025-06-27

Family

ID=82799923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578050A Pending JP2024525368A (ja) 2021-07-01 2022-07-01 アゼチジニルピリミジンおよびその使用

Country Status (10)

Country Link
US (1) US20240425496A1 (cg-RX-API-DMAC7.html)
EP (1) EP4363058A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024525368A (cg-RX-API-DMAC7.html)
KR (1) KR20240031347A (cg-RX-API-DMAC7.html)
CN (1) CN117642395A (cg-RX-API-DMAC7.html)
AU (2) AU2022304597C1 (cg-RX-API-DMAC7.html)
CA (1) CA3225872A1 (cg-RX-API-DMAC7.html)
IL (1) IL309892A (cg-RX-API-DMAC7.html)
MX (1) MX2024000273A (cg-RX-API-DMAC7.html)
WO (1) WO2023279105A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4547660A1 (en) * 2022-06-29 2025-05-07 Alcon Inc. Azetidinyl pyrimidines and uses thereof as jak inhibitors
EP4646415A1 (en) 2023-01-04 2025-11-12 Alcon Inc. Polymorphs of a jak1/tyk2 inhibitor and uses thereof
WO2024148184A1 (en) * 2023-01-04 2024-07-11 Aerie Pharmaceuticals, Inc. Compounds and processes for the preparation of jak inhibitors
CN116903592B (zh) * 2023-07-13 2025-08-01 特科罗生物科技(成都)有限公司 一种嘧啶胺类nuak抑制剂及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1966207A2 (en) * 2005-12-21 2008-09-10 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
WO2008132502A1 (en) * 2007-04-25 2008-11-06 Astrazeneca Ab Pyrazolyl-amino-substituted pyrimidines and their use for the treatment of cancer
KR101600278B1 (ko) * 2008-06-12 2016-03-08 얀센 파마슈티카 엔.브이. 히스타민 h4 수용체의 다이아미노-피리딘, 피리미딘, 및 피리다진 조절제
WO2018195450A1 (en) * 2017-04-21 2018-10-25 Epizyme, Inc. Combination therapies with ehmt2 inhibitors
TWI740288B (zh) * 2018-11-27 2021-09-21 大陸商江蘇豪森藥業集團有限公司 含氮雜芳類衍生物調節劑、其製備方法和應用
CN110317176A (zh) * 2019-07-04 2019-10-11 沈阳药科大学 2-氨基嘧啶类化合物及其用途
TW202227418A (zh) * 2020-10-12 2022-07-16 大陸商四川海思科製藥有限公司 一種雜環衍生物及其在醫藥上的應用
WO2022216098A1 (ko) * 2021-04-08 2022-10-13 주식회사 스탠다임 신규한 lrrk2 억제제

Similar Documents

Publication Publication Date Title
JP2023509422A5 (cg-RX-API-DMAC7.html)
JP2024529527A5 (cg-RX-API-DMAC7.html)
AU2017233841B2 (en) Pyrimidines and variants thereof, and uses therefor
ES2494846T3 (es) Derivados de pirazol como moduladores del receptor de la serotonina 5-HT2A útiles para el tratamiento de los trastornos relacionados con el mismo
JP2023540228A5 (cg-RX-API-DMAC7.html)
CN111247152B (zh) 作为激酶抑制剂的环状亚氨基嘧啶衍生物
JP2022507065A5 (cg-RX-API-DMAC7.html)
JP2021523112A5 (cg-RX-API-DMAC7.html)
WO2022088551A1 (zh) 吲唑类衍生物及其制备方法和应用
BR112015028501B1 (pt) Compostos derivados de bipirazol, seus sais, composição compreendendo o composto ou o sal, método de inibição in vitro de uma atividade de jak1, e processo de preparação de sal de ácido fosfórico
PT674642E (pt) Pirazolopirimidinas como antagonistas de crf
RU2002131941A (ru) 3-азот-6,7-дикислородсодержащие стероиды и их применение
JP2022507506A5 (cg-RX-API-DMAC7.html)
PT1711481E (pt) Processo para preparar carboxamidas 2-aminotiazol-5-aromáticas como inibidores de quinases
JP6407955B2 (ja) クマリン誘導体、ならびに過剰増殖疾患を治療する際の使用方法
AU2008255815B2 (en) Tetrahydroisoquinolin-1-one derivative or salt thereof
AU2004232682A1 (en) Isoquinoline-5-sulfonic acid amides as inhibitors of Akt (protein kinase B)
CN113226322A (zh) 作为bet抑制剂的杂环化合物
JP2022506898A5 (cg-RX-API-DMAC7.html)
JP2021522262A5 (cg-RX-API-DMAC7.html)
TW202024069A (zh) 含氮雜芳類衍生物調節劑、其製備方法和應用
CA2871453A1 (en) Quinazolinedione derivative
JP2022542140A5 (cg-RX-API-DMAC7.html)
KR20150016248A (ko) 불소 함유 아미노산의 프로드러그
JP2022507505A5 (cg-RX-API-DMAC7.html)